Inventor

JENSEN MICHAEL C

US45 patents

⚠️ This page may combine multiple inventors who share the name “JENSEN MICHAEL C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JENSEN MICHAEL C

SEATTLE CHILDRENS HOSPITAL

Method and compositions for cellular immunotherapy

Drug regulated transgene expression

Transgene genetic tags and methods of use

Bispecific CAR T-cells for solid tumor targeting

Methods of use for CAR T cells

Drug regulated transgene expression

Bispecific CAR T-cells for solid tumor targeting

Transgene genetic tags and methods of use

Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment

Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents

Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells

Enhancing endonuclease based gene editing in primary cells

Defined composition gene modified T-cell products

Transgene genetic tags and methods of use

Drug regulated transgene expression

Methods and compositions comprising B7H3 chimeric antigen receptors

Generating mammalian T cell activation inducible synthetic promoters (SYN+PRO) to improve T cell therapy

Early intervention methods to prevent or ameliorate toxicity

Early intervention methods to prevent or ameliorate toxicity

Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection

Genetic engineering of macrophages for immunotherapy

Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors

Anti-dinitrophenol chimeric antigen receptors

Closed-system manufacturing process for CAR-T cells

Nucleic acids encoding IL-13 receptor alpha 2 (IL13Ra2) chimeric antigen receptor for tumor specific T cell immunotherapy

HOPE CITY

CD19-specific chimeric T cell receptor

CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies

Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

Adoptive transfer of CD8+ T cell clones derived from central memory cells

Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection

Adoptive transfer of CD8+ T cell clones derived from central memory cells

UNIV CALIFORNIA

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19

Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19

HUTCHINSON FRED CANCER RES

Method and compositions for cellular immunotherapy

Method and compositions for cellular immunotherapy

Method and compositions for cellular immunotherapy

PURDUE RESEARCH FOUNDATION

Methods of use for CAR T cells

Sequencing method for CAR T cell therapy

JENSEN MICHAEL C

Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

ENDOCYTE INC

Methods of use for CAR T cells

SMOLKE CHRISTINA D

Genetic control of mammalian cells with synthetic RNA regulatory systems